Guardian Therapeutics Inc
Guardian Therapeutics Inc., based in Lexington, MA, is at the forefront of aptamer technology, focusing on the discovery and engineering of drug-like aptamer therapeutics. With a strong emphasis on hematology, dermatology, gastroenterology, and oncology, the company aims to unlock the full potential of aptamer-based treatments.
Utilizing a rapid discovery process, Guardian Therapeutics employs deep sequencing and high-throughput aptamer synthesis to develop high-affinity aptamers that can effectively disrupt protein-protein interactions. Their innovative approach ensures that these aptamers remain stable in serum and simulated gastric fluid, paving the way for significant therapeutic advancements.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

